Kenan Midilli
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 10
- Infectious Diseases top 5%
- Viral Infections and Vectors 12
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 8
- Parasitology top 5%
- Vector-borne infectious diseases 7
- Endocrinology top 5%
-
- Vector-Borne Animal Diseases 9
-
- Hepatitis B Virus Studies 8
-
- Hepatitis C virus research 7
- Co-authors
- Ayşen GargılıMert Ahmet KuşkucuSevgi ErginÖnder ErgönülRecep ÖztürkGönül ŞengözZerrin AktaşMurat Elevli
- Journals
- International Journal of Infectious Diseases (5 papers)Vaccines (2 papers)Vector-Borne and Zoonotic Diseases (2 papers)
- Partner nations
- TürkiyeUnited StatesCzechia
In The Last Decade
Kenan Midilli
84 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 235
- Applied Microbiology and Biotechnology 60
- Infectious Diseases 550
- Parasitology 164
- Endocrinology 99
Countries citing papers authored by Kenan Midilli
This map shows the geographic impact of Kenan Midilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenan Midilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenan Midilli more than expected).
Fields of papers citing papers by Kenan Midilli
This network shows the impact of papers produced by Kenan Midilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenan Midilli. The network helps show where Kenan Midilli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenan Midilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 2 | |
| 10 | 2018 | 0 | |
| 11 | 2015 | 10 | |
| 12 | 2012 | 58 | |
| 13 | Doğal yaşamdaki kaplumbağa ve kirpilerin kenelerinde zoonotik Borrelia burgdorferi sl ve Rickettsia spp varlığı | 2011 | 1 |
| 14 | 2011 | 0 | |
| 15 | 2010 | 25 | |
| 16 | First record of Borrelia spielmani in Turkey. | 2010 | 2 |
| 17 | 2009 | 13 | |
| 18 | 2009 | 32 | |
| 19 | 2008 | 4 | |
| 20 | 2006 | 15 |
About Kenan Midilli
Kenan Midilli is a scholar working on Infectious Diseases, Molecular Medicine, Endocrinology, Parasitology and Applied Microbiology and Biotechnology, having authored 89 papers that have together received 1.1k indexed citations. Recurring topics across this work include Viral Infections and Vectors (12 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Antibiotic Resistance in Bacteria (10 papers), Vector-Borne Animal Diseases (9 papers), COVID-19 Clinical Research Studies (8 papers), Hepatitis B Virus Studies (8 papers), Vector-borne infectious diseases (7 papers) and Hepatitis C virus research (7 papers). The work is most often cited by research in Molecular Medicine (235 citations), Applied Microbiology and Biotechnology (60 citations), Infectious Diseases (550 citations), Parasitology (164 citations) and Endocrinology (99 citations). Kenan Midilli has collaborated with scholars based in Türkiye, United States and Czechia. Frequent co-authors include Ayşen Gargılı, Mert Ahmet Kuşkucu, Sevgi Ergin, Önder Ergönül, Recep Öztürk, Gönül Şengöz, Zerrin Aktaş, Murat Elevli, Gökhan Aygün and Sırrı Kar. Their work appears in journals such as International Journal of Infectious Diseases, Vaccines, Vector-Borne and Zoonotic Diseases, BMC Infectious Diseases and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.